HOLLENCREST CAPITAL MANAGEMENT
Position in GILD — Gilead Sciences, Inc.
CIK 1161722
NEWPORT BEACH, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$93,996
-$20,566 QoQ
Shares Held
744
-9.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,001
of 2,265 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Dec 31, 2025CallValue
$12,274
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLLENCREST CAPITAL MANAGEMENT holds $5,976,653 across 13 Drug Manufacturers - General names. GILD ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
4,074 | $1,475,276 | |
| 2 | ABBV |
AbbVie Inc.
|
5,785 | $1,455,737 | |
| 3 | JNJ |
Johnson & Johnson
|
4,993 | $1,268,072 | |
| 4 | LLY |
ELI LILLY & Co
|
768 | $921,162 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,878 | $626,823 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
744 | $93,996 | |
| 7 | NVO |
Novo Nordisk A S
|
1,841 | $88,257 | |
| 8 | PFE |
Pfizer Inc
|
881 | $21,214 |
All Filings in GILD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,996 | 744 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $114,562 | 822 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $98,314 | 801 | Shares | Sole | 2026-02-12 | |
| 2025-12-31 | $12,274 | 100 | Call | Sole | 2026-02-12 | |
| 2025-09-30 | $80,031 | 721 | Shares | Sole | 2025-11-03 | |
| 2025-09-30 | $33,300 | 300 | Call | Sole | 2025-11-03 | |
| 2025-06-30 | $79,937 | 721 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $149,138 | 1,331 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $123,221 | 1,334 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $111,842 | 1,334 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $91,319 | 1,331 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $97,495 | 1,331 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $107,824 | 1,331 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $62,125 | 829 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $63,891 | 829 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $68,782 | 829 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $71,169 | 829 | Shares | Sole | 2023-02-07 | |
| 2021-12-31 | $1,060,759 | 14,609 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $929,632 | 13,309 | Shares | Sole | 2021-10-13 | |
| 2020-03-31 | $941,751 | 12,597 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||